Keyphrases
Antipsychotics
100%
Glucagon-like
62%
Receptor Agonist
60%
A1 Receptor
60%
Cocaine
52%
Schizophrenia
52%
Aripiprazole
49%
Schizophrenia Spectrum Disorders
45%
Muscarinic Receptors
37%
M4 Receptor
37%
Clozapine
34%
Monkey
32%
Olanzapine
31%
Psychosis
30%
Tolerability
29%
First-episode Psychosis
27%
Cocaine-induced
27%
Alcohol
27%
Alcohol Intake
27%
Knock-in Mouse Model
26%
Pre-diabetes (pre-DM)
26%
Cocaine Self-administration
24%
Exendin-4 (Ex-4)
24%
Socially Isolated
24%
Nucleus Accumbens
24%
Schizophrenic Patients
23%
Odds Ratio
23%
Dopamine Homeostasis
23%
Dopamine
22%
Overweight or Obesity
22%
Sudden Cardiac Death
22%
Neuropeptide Y
22%
Liraglutide
22%
Alcohol Consumption
21%
Patients with Schizophrenia
21%
Denmark
18%
Confidence Interval
18%
Quetiapine
18%
Psychiatric Patients
18%
Xanomeline
17%
Muscarinic Acetylcholine Receptor
16%
Antipsychotic-like Effect
16%
Psychiatric Hospital
16%
Receptor Knockout
16%
Total Knee Arthroplasty
15%
Psychopharmacotherapy
15%
Placebo
15%
Metabolic Syndrome
15%
Risk Factors
15%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
76%
Receptor
53%
Muscarinic Receptor
52%
Knockout Mouse
45%
Ethanol
44%
Glucagon Like Peptide 1 Receptor Agonist
41%
Aripiprazole
33%
Quetiapine
31%
Olanzapine
28%
Schizophrenia Spectrum Disorder
27%
Psychosis
26%
Exendin 4
25%
Hyperactivity
24%
Adverse Event
24%
Clozapine
23%
Cohort Study
22%
Dopamine Receptor Stimulating Agent
20%
Glucagon-Like Peptide-1
20%
Sudden Cardiac Death
19%
Liraglutide
19%
Placebo
19%
Obesity
18%
Receptor Subtype
17%
Xanomeline
16%
Extrapyramidal Symptom
15%
Neuroscience
Antipsychotic
64%
Receptor
43%
Muscarinic Acetylcholine Receptor
33%
Muscarinic Acetylcholine Receptor M4
29%
Glucagon-Like Peptide-1 Agonist
29%
Aripiprazole
26%
Negative Syndrome
25%
Behavior (Neuroscience)
24%
Social Isolation
22%
Exenatide
22%
Psychosis
21%
Hyperactivity
20%
Positive Syndrome
20%
Quetiapine
18%
Meta-Analysis
18%
Locomotor Activity
18%
Schizophrenia Spectrum Disorder
18%
Conditioned Place Preference
18%
Nucleus Accumbens
17%
Olanzapine
17%
Dopaminergic
17%
Amphetamine
16%